Search
Browse By Day
Browse By Person
Browse By Room
Browse By Research Area
Browse By Session Type
Search Tips
Meeting Home Page
Personal Schedule
Sign In
In the early 2000s, the Japanese government turned itself as a key stakeholder in advancement of science and technology in the country, and launched several large-scale national projects, including those on stem cell science (Mikami 2015) and structural genomics (Fukushima 2015). And one such project was the National Bio-Resource Project (NBRP). This project differs from others in that it does not aim to produce scientific knowledge or to develop novel technology: instead, it builds research infrastructure that serves primarily for the community of life science researchers in the country.
In this paper, I examine the relationship between the way this national project is evaluated and the practices that aimed to enhance its value. It was launched initially as a five-year project, and just like other research projects, it needed to demonstrate its value to justify the investment the government made in order to continue beyond the five-year period. However, this turned out to be a rather challenging task for those involved in it, not because frequently used indicators for research projects, like a number of publications and patents, were considered inappropriate, but because they have to be of those who made use of resource(s) supplied by the project. Based on a series of interviews with those who oversee the overall project and also those who manage each resource, I argue that the evaluation of this infrastructure serves to facilitate its assetization, stabilizing its value as a source of future benefits for the country (Birch 2016).